BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32905326)

  • 1.
    Katt ME; Shusta EV
    Curr Opin Chem Eng; 2020 Dec; 30():42-52. PubMed ID: 32905326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Models of the Blood-Brain Barrier.
    Raut S; Bhalerao A; Noorani B; Cucullo L
    Methods Mol Biol; 2022; 2492():25-49. PubMed ID: 35733037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An isogenic hiPSC-derived BBB-on-a-chip.
    Motallebnejad P; Thomas A; Swisher SL; Azarin SM
    Biomicrofluidics; 2019 Nov; 13(6):064119. PubMed ID: 31768205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
    Wang YI; Abaci HE; Shuler ML
    Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Three-Dimensional Cell Culture System To Model RNA Virus Infections at the Blood-Brain Barrier.
    Bramley JC; Drummond CG; Lennemann NJ; Good CA; Kim KS; Coyne CB
    mSphere; 2017; 2(3):. PubMed ID: 28656176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Models of the Blood-Brain Barrier.
    Neuhaus W
    Handb Exp Pharmacol; 2021; 265():75-110. PubMed ID: 32562060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What human blood-brain barrier models can tell us about BBB function and drug discovery?
    Ferreira L
    Expert Opin Drug Discov; 2019 Nov; 14(11):1113-1123. PubMed ID: 31385723
    [No Abstract]   [Full Text] [Related]  

  • 9. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
    Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
    Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Microfluidic Blood-Brain Barrier (BBB) Models.
    Oddo A; Peng B; Tong Z; Wei Y; Tong WY; Thissen H; Voelcker NH
    Trends Biotechnol; 2019 Dec; 37(12):1295-1314. PubMed ID: 31130308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines.
    Kitamura K; Umehara K; Ito R; Yamaura Y; Komori T; Morio H; Akita H; Furihata T
    Biol Pharm Bull; 2021 Jul; 44(7):984-991. PubMed ID: 33896887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain.
    Modarres HP; Janmaleki M; Novin M; Saliba J; El-Hajj F; RezayatiCharan M; Seyfoori A; Sadabadi H; Vandal M; Nguyen MD; Hasan A; Sanati-Nezhad A
    J Control Release; 2018 Mar; 273():108-130. PubMed ID: 29378233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro models of the blood-brain barrier.
    Czupalla CJ; Liebner S; Devraj K
    Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models of the blood-brain barrier using iPSC-derived cells.
    Delsing L; Herland A; Falk A; Hicks R; Synnergren J; Zetterberg H
    Mol Cell Neurosci; 2020 Sep; 107():103533. PubMed ID: 32717317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularized neural constructs for ex-vivo reconstitution of blood-brain barrier function.
    Yue H; Xie K; Ji X; Xu B; Wang C; Shi P
    Biomaterials; 2020 Jul; 245():119980. PubMed ID: 32229330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier on a chip.
    Chin E; Goh E
    Methods Cell Biol; 2018; 146():159-182. PubMed ID: 30037460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modeling of the blood-brain barrier: simplicity versus complexity.
    Ogunshola OO
    Curr Pharm Des; 2011; 17(26):2755-61. PubMed ID: 21827410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.